NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Price, Forecast & Analysis

NASDAQ:NMTC • US64130M2098

0.8132 USD
+0.06 (+7.84%)
At close: Feb 13, 2026
0.797 USD
-0.02 (-1.99%)
After Hours: 2/13/2026, 8:00:01 PM

NMTC Key Statistics, Chart & Performance

Key Statistics
Market Cap41.01M
Revenue(TTM)12.10M
Net Income(TTM)-3.60M
Shares50.43M
Float43.93M
52 Week High1.25
52 Week Low0.4
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.08
PEN/A
Fwd PEN/A
Earnings (Next)02-17
IPO2012-11-09
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
NMTC short term performance overview.The bars show the price performance of NMTC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 15

NMTC long term performance overview.The bars show the price performance of NMTC in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of NMTC is 0.8132 USD. In the past month the price decreased by -9.54%. In the past year, price decreased by -32.23%.

NEUROONE MEDICAL TECHNOLOGIE / NMTC Daily stock chart

NMTC Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to NMTC. When comparing the yearly performance of all stocks, NMTC is a bad performer in the overall market: 75.47% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
NMTC Full Technical Analysis Report

NMTC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NMTC. The financial health of NMTC is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NMTC Full Fundamental Analysis Report

NMTC Financial Highlights

Over the last trailing twelve months NMTC reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 83.41% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -33.38%
ROE -50.91%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%63.64%
Sales Q2Q%915.16%
EPS 1Y (TTM)83.41%
Revenue 1Y (TTM)250.35%
NMTC financials

NMTC Forecast & Estimates

8 analysts have analysed NMTC and the average price target is 2.35 USD. This implies a price increase of 188.49% is expected in the next year compared to the current price of 0.8132.

For the next year, analysts expect an EPS growth of -97.62% and a revenue growth 26.51% for NMTC


Analysts
Analysts85
Price Target2.35 (188.98%)
EPS Next Y-97.62%
Revenue Next Year26.51%
NMTC Analyst EstimatesNMTC Analyst Ratings

NMTC Ownership

Ownership
Inst Owners33.27%
Ins Owners4.14%
Short Float %0.11%
Short Ratio0.17
NMTC Ownership

NMTC Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.62195.936B
ISRG INTUITIVE SURGICAL INC47.53172.536B
SYK STRYKER CORP24.21139.985B
BSX BOSTON SCIENTIFIC CORP21.34110.826B
IDXX IDEXX LABORATORIES INC42.4850.254B
BDX BECTON DICKINSON AND CO11.1650.113B
EW EDWARDS LIFESCIENCES CORP25.5244.027B
RMD RESMED INC20.5736.792B
GEHC GE HEALTHCARE TECHNOLOGY1636.615B
DXCM DEXCOM INC27.7327.309B

About NMTC

Company Profile

NMTC logo image NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. The company is headquartered in Eden Prairie, Minnesota and currently employs 18 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

Company Info

NEUROONE MEDICAL TECHNOLOGIE

7599 Anagram Dr

Eden Prairie MINNESOTA US

Employees: 18

NMTC Company Website

NMTC Investor Relations

Phone: 19524261383

NEUROONE MEDICAL TECHNOLOGIE / NMTC FAQ

What does NMTC do?

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. The company is headquartered in Eden Prairie, Minnesota and currently employs 18 full-time employees. The company went IPO on 2012-11-09. The company is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.


Can you provide the latest stock price for NEUROONE MEDICAL TECHNOLOGIE?

The current stock price of NMTC is 0.8132 USD. The price increased by 7.84% in the last trading session.


Does NMTC stock pay dividends?

NMTC does not pay a dividend.


What is the ChartMill rating of NEUROONE MEDICAL TECHNOLOGIE stock?

NMTC has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the market capitalization of NMTC stock?

NEUROONE MEDICAL TECHNOLOGIE (NMTC) has a market capitalization of 41.01M USD. This makes NMTC a Nano Cap stock.


Can you provide the upcoming earnings date for NEUROONE MEDICAL TECHNOLOGIE?

NEUROONE MEDICAL TECHNOLOGIE (NMTC) will report earnings on 2026-02-17.


What is the ownership structure of NEUROONE MEDICAL TECHNOLOGIE (NMTC)?

You can find the ownership structure of NEUROONE MEDICAL TECHNOLOGIE (NMTC) on the Ownership tab.